Sleep apnea syndrome
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for Objective 1: 1.Patients who started SAS treatment under the code for diagnosis of SAS from April 2015 to February 2021 2.Patients traceable during the look-back period (365 days prior to the index date, the date on which SAS treatment was started) 3.Patients 18 years old and over in the index month (the month in which SAS treatment was started) 4.Insurance subscribers who have obtained permission to use dental claims data Inclusion criteria for Objective 2: 1.Patients who started CPAP therapy only, without other therapy, on the index date and were among the study population for Objective 1
Exclusion criteria
Exclusion criteria: Exclusion criteria for Objective 1: 1.Patients with a history of SAS treatment during the look-back period Exclusion criteria for Objective 2: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Patient demographics and actual clinical practice in patients who have started SAS treatment 2. Treatment duration and predictors for persistence in patients who have started CPAP therapy 1) Duration of CPAP therapy 2) Predictors for persistence in CPAP therapy 3) Actual clinical practice in patients who have dropped out of CPAP therapy 4) Changes in body weight after CPAP therapy | — |
Countries
Japan
Contacts
Teijin Pharma Limited Medical Science Department